Teligent Inc
NASDAQ:TLGT (10/15/2021, 7:08:54 PM)
After market: 0.1717 0 (-1.04%)0.1735
-0.03 (-13.85%)
Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. The company is headquartered in Buena, New Jersey and currently employs 142 full-time employees. The firm is focused on the development, manufacturing and marketing of a portfolio of generic pharmaceutical products under its own label and private label for other pharmaceutical companies in topical, injectable, complex and other dosage forms. The company also provides contract development and manufacturing services to the prescription and over-the-counter (OTC) pharmaceutical and cosmetic markets. Under the Company's own label, it markets and sells generic topical, and generic and branded generic injectable pharmaceutical products in the United States and Canada. In the United States, the Company markets approximately 37 generic topical pharmaceutical products and one branded injectable pharmaceutical product. In Canada, it markets approximately 24 generic injectable, one generic topical and three generic ophthalmic products.
Teligent Inc
105 Lincoln Avenue
Buena NEW JERSEY 08310
P: 18566971441.0
CEO: Timothy B. Sawyer
Employees: 142
Website: http://www.teligent.com/
/PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that...
Are these top penny stocks to watch on your list in September?
Here you can normally see the latest stock twits on TLGT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: